Figure 1.
Figure 1. K562 (WT) and IR K562 (RES) cells were treated with combinations of imatinib or dasatinib plus SNDX-275. Individual points represent CIs at different levels of growth inhibition.

K562 (WT) and IR K562 (RES) cells were treated with combinations of imatinib or dasatinib plus SNDX-275. Individual points represent CIs at different levels of growth inhibition.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal